2024-10-29 10:24:48
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma
Corporate/ 2023-07-23
Antengene Announces the Approval of Firs...

SEOUL,South Korea and SHANGHAI and HONG KONG,Aug. 2,2021--Antengene Corporation Limited ("Antengene",SEHK: 6996.HK),a leading inno...

JAPSC: Journal of Asian Pacific Society of Cardiology Launches and Welcomes Submissions
Health/ 2023-07-22
JAPSC: Journal of Asian Pacific Society ...

LONDON,Aug. 2,2021--The Radcliffe Group is pleased to announce that JAPSC: Journal of Asian Pacific Societyof Cardiologyis now open to submi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release